Pulmonary pathology in fatal intravenous heroin addicts Source: Eur Respir J 2003; 22: Suppl. 45, 268s Year: 2003
Severe respiratory illness in an intravenous drug abuser Source: ISSN=ISSN 1810-6838, ISBN=, page=207 Year: 2006
Lung injury in intravenous drug users with infective endocarditis Source: Annual Congress 2011 - Clinical features of pulmonary hypertension Year: 2011
Septic pulmonary embolism in intravenous drug users. Source: International Congress 2017 – Pulmonary embolism Year: 2017
Pulmonary complications of infective endocarditis in intravenous drug users Source: Eur Respir J 2001; 18: Suppl. 33, 521s Year: 2001
Pulmonary onset and complications of intravenous drug users infective endocarditis Source: International Congress 2018 – Diagnosis, prognostication and treatment of pulmonary embolism Year: 2018
Predictors of tuberculosis in injection drug users Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019
Secondary drug resistance during an intravenous intermittent chemotherapy in newly cases TB Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2011
Problems of treatment of TB patients suffering from alcohol and drugs addiction Source: Eur Respir J 2002; 20: Suppl. 38, 369s Year: 2002
Adverse effects of chemotherapy in patients with multidrug-resistant tuberculosis with alcohol abuse and without one Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis Year: 2018
Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP Source: Eur Respir J 2013; 41: 123-130 Year: 2013
Switch from intravenous to oral antibiotic therapy in hospitalized patients with non-severe community acquired pneumonia Source: Annual Congress 2010 - New aspects of treatment of lower respiratory tract infections Year: 2010
Evaluation of antituberculous drugs administration Source: Eur Respir J 2002; 20: Suppl. 38, 547s Year: 2002
Hepatotoxicity due to antituberculosis drug treatment Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis II Year: 2008
Stating the obvious: intravenous magnesium sulphate should be the first parenteral bronchodilator in paediatric asthma exacerbations unresponsive to first-line therapy Source: Breathe, 17 (4) 210113; 10.1183/20734735.0113-2021 Year: 2021
Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with pulmonary infections Source: Eur Respir J 2006; 28: Suppl. 50, 275s Year: 2006
Expression of inflammatory cytokines following stepwise dose reduction of corticosteroids of long-term oral corticosteroids users with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 62s Year: 2004
Serum pharmacokinetics of antituberculosis drugs in volunteers Source: Eur Respir J 2004; 24: Suppl. 48, 721s Year: 2004
Adjunctive systemic corticosteroid treatment in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012
Combination therapy in severe pulmonary hypertension with bosentan and treprostinil: successful switch from subcutaneous to intravenous application Source: Eur Respir J 2006; 28: Suppl. 50, 384s Year: 2006